Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

A new study finds that biologic therapies significantly reduce the risk of heart attacks and strokes in patients with psoriasis or psoriatic arthritis. Learn more about the cardiovascular benefits of ...

Psoriasis doesn’t prevent you from having a cosmetic procedure, but there are safety and timing concerns to consider. Learn ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

Immunosuppressants can help reduce the effects of the immune ... In addition to treating PsA, biologics can treat psoriasis symptoms. It’s possible that you’ll be prescribed a biologic in ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Opens in a new tab or window Until about 20 years ago, systemic treatment ... and biologic therapies remained in various stages of development. The most recent AAD/National Psoriasis Foundation ...

Psoriasis doesn’t have a cure, but a combination of home and medical treatments can help relieve flare-ups and symptoms. A doctor may also recommend you try light therapy to treat pain and ...

Seeking treatment for depression ... and some experts believe biologic treatments for psoriasis may help prevent PsA from developing. While more work is needed to confirm this, ensuring everyone ...